Published in Lancet on February 28, 1980
Homeopathic arnica for prevention of pain and bruising: randomized placebo-controlled trial in hand surgery. J R Soc Med (2003) 3.92
Population dynamics of flaviviruses revealed by molecular phylogenies. Proc Natl Acad Sci U S A (1996) 3.69
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology (2005) 3.45
First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality! Clin Microbiol Infect (2010) 2.53
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Tick-borne encephalitis. Antiviral Res (2003) 2.25
Phylogenetic relationships of flaviviruses correlate with their epidemiology, disease association and biogeography. J Gen Virol (2001) 2.19
The relationships between West Nile and Kunjin viruses. Emerg Infect Dis (2001) 2.03
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol (2007) 1.97
Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology (1991) 1.85
Complete coding sequence of the Alkhurma virus, a tick-borne flavivirus causing severe hemorrhagic fever in humans in Saudi Arabia. Biochem Biophys Res Commun (2001) 1.85
Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res (1997) 1.84
Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol (1982) 1.77
An arbovirus cline across the northern hemisphere. Virology (1995) 1.67
Cinnamoyl CoA reductase, the first committed enzyme of the lignin branch biosynthetic pathway: cloning, expression and phylogenetic relationships. Plant J (1997) 1.64
Complete sequence of two tick-borne flaviviruses isolated from Siberia and the UK: analysis and significance of the 5' and 3'-UTRs. Virus Res (1997) 1.63
Molecular epidemiology of dengue virus type 3 in Venezuela. J Gen Virol (2003) 1.61
Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants. J Pediatr (1994) 1.59
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. J Gen Virol (1987) 1.53
Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. J Gen Virol (1985) 1.50
Porcine dendritic cells generated in vitro: morphological, phenotypic and functional properties. Immunology (2001) 1.49
European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine (2003) 1.48
Molecular epidemiology of dengue type 2 virus in Venezuela: evidence for in situ virus evolution and recombination. J Gen Virol (2001) 1.48
A reevaluation of the higher taxonomy of viruses based on RNA polymerases. J Virol (1996) 1.44
Succinylcholine-assisted intubations in prehospital care. Ann Emerg Med (1988) 1.44
Job-based health insurance in 2001: inflation hits double digits, managed care retreats. Health Aff (Millwood) (2001) 1.32
Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR. Virology (1995) 1.32
Changes in the male voice at puberty: vocal fold length and its relationship to the fundamental frequency of the voice. J Laryngol Otol (1998) 1.31
Nucleotide sequence of the envelope glycoprotein of Negishi virus shows very close homology to louping ill virus. Virology (1992) 1.29
Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J Gen Virol (1993) 1.28
Secondary structure of the 3'-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development. J Gen Virol (1997) 1.28
A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles. Microb Pathog (1996) 1.28
Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J Virol (1998) 1.28
Changes in the male voice at puberty. Arch Dis Child (1997) 1.27
Infection patterns in mice of an avirulent and virulent strain of Semliki Forest virus. Br J Exp Pathol (1971) 1.26
Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies. J Med Microbiol (1991) 1.26
The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry Suppl (1992) 1.24
Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res (1995) 1.24
Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology (1986) 1.24
Association of lymphopenia with porcine circovirus type 2 induced postweaning multisystemic wasting syndrome (PMWS). Vet Immunol Immunopathol (2003) 1.23
Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. Arch Virol (1982) 1.23
Carotid artery thrombosis, encephalitis, myelitis and optic neuritis associated with rubella virus infections. Brain (1975) 1.23
Biological consequences of deletions within the 3'-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res (1999) 1.22
Phylogeny of TYU, SRE, and CFA virus: different evolutionary rates in the genus Flavivirus. Virology (1995) 1.17
The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies. J Gen Virol (1986) 1.16
Detection of virus-specific antigen in the nuclei or nucleoli of cells infected with Zika or Langat virus. J Gen Virol (1988) 1.16
Job-based health insurance in 2000: premiums rise sharply while coverage grows. Health Aff (Millwood) (2000) 1.16
Phylogeny of the genus flavivirus using complete coding sequences of arthropod-borne viruses and viruses with no known vector. J Gen Virol (2000) 1.14
Recombination in rabbit haemorrhagic disease virus: possible impact on evolution and epidemiology. Virology (2008) 1.13
Antibody-mediated early death in vivo after infection with yellow fever virus. J Gen Virol (1986) 1.13
Immunopathogenesis of classical swine fever: role of monocytic cells. Immunology (1999) 1.13
Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology (1987) 1.12
A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. J Virol Methods (1985) 1.11
Towards a new generation of flavivirus vaccines. Vaccine (1994) 1.10
Monoclonal antibodies: implications for virology. Brief review. Arch Virol (1986) 1.10
Screening slaughtered cattle for BSE. Nature (2001) 1.09
Origin and evolution of 3'UTR of flaviviruses: long direct repeats as a basis for the formation of secondary structures and their significance for virus transmission. Adv Virus Res (2007) 1.09
A study of a patient with the amyotrophic form of Creutzfeldt-Jakob disease. Brain (1971) 1.09
Biochemical characterization, molecular cloning and expression of laccases - a divergent gene family - in poplar. Eur J Biochem (1999) 1.09
High IFN-alpha responses associated with depletion of lymphocytes and natural IFN-producing cells during classical swine fever. J Interferon Cytokine Res (2006) 1.09
Evolution of base composition and codon usage bias in the genus Flavivirus. J Mol Evol (2001) 1.07
The virus causing encephalomyelitis in sheep in Spain: a new member of the tick-borne encephalitis group. Res Vet Sci (1995) 1.06
Studies of the basis of localization of influenza virus in ferret organ cultures. Br J Exp Pathol (1972) 1.05
Identification of naturally occurring monoclonal antibody escape variants of louping ill virus. J Gen Virol (1994) 1.05
Porcine bone marrow myeloid cells: phenotype and adhesion molecule expression. J Leukoc Biol (1997) 1.04
Dendritic cells harbor infectious porcine circovirus type 2 in the absence of apparent cell modulation or replication of the virus. J Virol (2003) 1.04
Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire. Virology (2006) 1.04
Rapid subgroup identification of the flaviviruses using degenerate primer E-gene RT-PCR and site specific restriction enzyme analysis. J Virol Methods (2005) 1.04
The production of a temperature-sensitive persistent measles virus infection. J Gen Virol (1975) 1.02
Characterization of a siberian virus isolated from a patient with progressive chronic tick-borne encephalitis. J Virol (2003) 1.02
Monoclonal antibodies identify the NS5 yellow fever virus non-structural protein in the nuclei of infected cells. J Gen Virol (1992) 1.02
Analysis of the structural protein gene sequence shows Kyasanur Forest disease virus as a distinct member in the tick-borne encephalitis virus serocomplex. J Gen Virol (1994) 1.02
Molecular epidemiology of Rabbit haemorrhagic disease virus. J Gen Virol (2002) 1.01
Interaction of classical swine fever virus with dendritic cells. J Gen Virol (2004) 1.01
Envelope protein sequences of dengue virus isolates TH-36 and TH-Sman, and identification of a type-specific genetic marker for dengue and tick-borne flaviviruses. J Gen Virol (1992) 1.00
A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator. Phys Med (2008) 1.00
Comparison of neurovirulence of different strains of yellow fever virus in mice. J Gen Virol (1986) 1.00
Use of the biotin-streptavidin interaction to improve flavivirus detection by immunofluorescence and ELISA tests. J Virol Methods (1985) 0.99
Modulation of monocytic cell activity and virus susceptibility during differentiation into macrophages. J Immunol (1999) 0.99
Differential accumulation of monolignol-derived compounds in elicited flax (Linum usitatissimum) cell suspension cultures. Planta (2005) 0.99
Phylogeny and molecular epidemiology of West Nile and Kunjin viruses. Curr Top Microbiol Immunol (2002) 0.98
Some characteristics of salt-dependent haemagglutinating measles viruses. J Gen Virol (1976) 0.98
ESTs from the fibre-bearing stem tissues of flax (Linum usitatissimum L.): expression analyses of sequences related to cell wall development. Plant Biol (Stuttg) (2005) 0.98
Classification of a new member of the TBE flavivirus subgroup by its immunological, pathogenetic and molecular characteristics: identification of subgroup-specific pentapeptides. Virus Res (1993) 0.97
Is rinderpest virus the archevirus of the Morbillivirus genus? Intervirology (1985) 0.97
Detection of antibody to bovine syncytial virus and respiratory syncytial virus in bovine fetal serum. J Clin Microbiol (1978) 0.97
Genome sequence analysis of Tamana bat virus and its relationship with the genus Flavivirus. J Gen Virol (2002) 0.97
Tracing the origins of louping ill virus by molecular phylogenetic analysis. J Gen Virol (1998) 0.96
Siva-1 negatively regulates NF-kappaB activity: effect on T-cell receptor-mediated activation-induced cell death (AICD). Oncogene (2006) 0.96
Direct cell to cell transfer of Bittner virus. J Gen Virol (1970) 0.96
Direct repeats in the 3' untranslated regions of mosquito-borne flaviviruses: possible implications for virus transmission. J Gen Virol (2006) 0.96
The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis. Apoptosis (2004) 0.96
Transmission of louping ill virus between infected and uninfected ticks co-feeding on mountain hares. Med Vet Entomol (1997) 0.96
Seroepidemiology of pertussis in Italy. Rev Infect Dis (1992) 0.96
Sequencing and antigenic studies of a Norwegian virus isolated from encephalomyelitic sheep confirm the existence of louping ill virus outside Great Britain and Ireland. J Gen Virol (1993) 0.95
Origin and evolution of flavivirus 5'UTRs and panhandles: trans-terminal duplications? Virology (2007) 0.95
Further studies on the early protective responses of pigs following immunisation with high potency foot and mouth disease vaccine. Vaccine (2002) 0.95